ctrl K

AEON Biopharma Inc. (AEON)

NASDAQ: AEON · Real-Time Price · USD

0.44

0.01 (1.62%)

At close: May 01, 2025, 3:59 PM

0.48

9.38%

Pre-market: May 02, 2025, 09:09 AM EDT

AEON Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13K	5.16M	9.75M	5.13M	20.17M	6.32M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	105.42M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	1.43M
Other Long-Term Assets	29K	29K	34K	360K	838K	778K
Receivables	n/a	n/a	n/a	n/a	n/a	267K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.58M	1.06M	92K	26K	n/a	n/a
Total Current Assets	1.59M	6.22M	9.84M	5.15M	20.38M	112.14M
Property-Plant & Equipment	1.52M	594K	906K	922K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.55M	623K	940K	1.28M	838K	2.21M
Total Assets	3.14M	6.84M	10.78M	6.44M	21.21M	114.35M
Account Payables	5.91M	3.39M	7.8M	1.19M	2.03M	1.02M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	70.87M	15.6M	n/a	14.79M
Other Current Liabilities	1.07M	943K	1.11M	1.07M	1.25M	809K
Total Current Liabilities	14.15M	13.05M	82.57M	20.8M	4.2M	17.5M
Long-Term Debt	11.69M	n/a	60.43M	70.76M	72.16M	15.16M
Other Long-Term Liabilities	4.73M	146.84M	137.95M	138.17M	148.09M	147.56M
Total Long-Term Liabilities	17.56M	146.84M	198.62M	209.46M	220.25M	162.73M
Total Liabilities	31.71M	159.89M	281.19M	230.26M	224.45M	180.22M
Total Debt	12.96M	278K	131.53M	86.89M	72.16M	29.95M
Common Stock	4K	4K	14K	14K	11K	11K
Retained Earnings	-431.6M	-473.6M	-474.84M	-422.28M	-366.65M	-333.73M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-28.57M	-153.04M	-287.5M	-234.94M	-208.27M	-67.15M
Total Investments	n/a	n/a	n/a	n/a	n/a	106.85M